IL33 and Alzheimer disease: Cognitive impairment in AD, in the light of the findings, might be attributed to decrease of IL-33 protein in association with downregulation of the IL-33 mRNA in the earlier stage of AD, but to restore it, translation of IL-33 protein might be stimulated as a compensatory function in the chronic stage.